We independently developed Aclatonium Napadisilate's new synthesis prescription and have already applied PCT patent.(International application number PCT/CN2007/070948. At present we have passed the international patent bureau's preliminary audit and now enter preparation stage. We plan to seek patent cooperation in Europe, USA, Japan, South Korea and the Middle East in the hope of sharing the patent interest with the company or individuals who are interested in our product and company and willing to cooperate with us in patent application in the above mentioned area. If you have any interest, please feel free to contact.